Pakistan finalizes national policy to boost local vaccine production

Pakistan government finalizes policy to boost local vaccine manufacturing

ISLAMABAD: In a major move to strengthen Pakistan’s healthcare system, the government has finalized a draft national policy aimed at promoting local vaccine manufacturing. The policy, which is designed to reduce the country’s reliance on imported vaccines, introduces a comprehensive set of financial incentives, tax exemptions, and regulatory support to attract both domestic and foreign investment into the vaccine sector.

Key features of the policy

The proposed policy includes significant fiscal and regulatory incentives to encourage the establishment of local vaccine manufacturing plants. Investors will benefit from up to 10 years of financial incentives, including tax relief on production inputs, corporate tax exemptions, and customs duty waivers on machinery and equipment. These measures aim to make vaccine production more affordable and efficient, encouraging long-term investment in the sector.

The policy also introduces a National Vaccine and Biology Fund, which aims to bridge the financing gap for vaccine production and other associated research efforts. Funding will be sourced from international institutions like the Asian Development Bank (ADB), World Bank, and Islamic Development Bank, as well as local financing sources.

Addressing Pakistan's vaccine import dependency

Currently, Pakistan imports vaccines worth around $340 million annually, a figure that is projected to rise to $1.2 billion between 2030 and 2035 if local vaccine production is not developed. This draft policy aims to reduce this dependence by creating a self-sufficient domestic vaccine industry, which could significantly benefit public health and national economic stability.

The policy also stresses the importance of preventive healthcare by proposing that vaccination against diseases such as hepatitis, malaria, and dengue be made more accessible, especially for the country’s newborns and children. The policy recognizes that local vaccine production is not only a health priority but also a matter of national health security.

Incentives for R&D and clinical trials

The draft policy also includes investment allowances for clinical trials, workforce training, and research and development. It also offers compensation mechanisms to protect investors in case of financial losses during the early stages of vaccine production. These incentives aim to ensure that Pakistan’s vaccine sector is not only self-sufficient but also competitive on a global scale.

A collaborative effort for long-term sustainability

In addition to these measures, the government plans to collaborate with various stakeholders, including the International Monetary Fund (IMF) and Federal Board of Revenue (FBR), to discuss tax exemptions and facilitate the implementation of the policy. The draft also suggests that the government will purchase quality-assured vaccines produced domestically for up to 10 years, while ensuring that the prices remain competitive with imported vaccines.

Conclusion and future outlook

The finalization of the vaccine policy marks a significant step towards making Pakistan’s healthcare system more resilient and self-reliant. As the policy enters its final stages, it is expected to reshape the future of vaccine production in the country, reduce reliance on imports, and promote a healthier population through better access to vaccines.

Stay informed and protect your health!

CLICK HERE TO JOIN Medical News Pakistan on WhatsApp for expert tips, health updates, and the latest medical research straight to your phone.